A Platform for the Discovery of New Macrolide Antibiotics

The chemical modification of structurally complex fermentation products, a process known as semisynthesis, has been an important tool in the discovery and manufacture of antibiotics for the treatment of various infectious diseases. However, many of the therapeutics obtained in this way are no longer effective, because bacterial resistance to these compounds has developed. Here we present a practical, fully synthetic route to macrolide antibiotics by the convergent assembly of simple chemical building blocks, enabling the synthesis of diverse structures not accessible by traditional semisynthetic approaches. More than 300 new macrolide antibiotic candidates, as well as the clinical candidate solithromycin, have been synthesized using our convergent approach. Evaluation of these compounds against a panel of pathogenic bacteria revealed that the majority of these structures had antibiotic activity, some efficacious against strains resistant to macrolides in current use. The chemistry we describe here provides a platform for the discovery of new macrolide antibiotics and may also serve as the basis for their manufacture.

[1]  Young Ji Yoo,et al.  Genetic engineering of macrolide biosynthesis: past advances, current state, and future prospects , 2010, Applied Microbiology and Biotechnology.

[2]  Yoshiaki Watanabe,et al.  Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A. , 1984, The Journal of antibiotics.

[3]  Andrew G Myers,et al.  The evolving role of chemical synthesis in antibacterial drug discovery. , 2014, Angewandte Chemie.

[4]  Luke G Green,et al.  A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. , 2002, Angewandte Chemie.

[5]  P. Balaram,et al.  Asymmetric total synthesis of erythromycin. 2. Synthesis of an erythronolide A lactone system , 1981 .

[6]  R. Berisio,et al.  Structural Insight into the Antibiotic Action of Telithromycin against Resistant Mutants , 2003, Journal of bacteriology.

[7]  R. Leclercq,et al.  Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  Andrew G Myers,et al.  A Convergent Enantioselective Route to Structurally Diverse 6-Deoxytetracycline Antibiotics , 2005, Science.

[9]  A. Hodgson,et al.  The Asymmetric Synthesis of Erythromycin B , 1997 .

[10]  Christopher T. Walsh,et al.  Antibiotics for Emerging Pathogens , 2009, Science.

[11]  Kazuo Banno,et al.  NEW ALDOL TYPE REACTION , 1973 .

[12]  H. Ishikawa,et al.  Specific hydromagnesiation of prop-2-ynylic alcohols. A simple and specific route to terpenoids , 1981 .

[13]  An Efficient Directed Claisen Reaction Allows for Rapid Construction of 5,6-Disubstituted 1,3-Dioxin-4-ones , 2015 .

[14]  S. Kang,et al.  Total synthesis of azithromycin. , 2009, Angewandte Chemie.

[15]  S. Douthwaite,et al.  The ketolides: a critical review. , 2002, Drugs.

[16]  R. Egan,et al.  Acid degradation of erythromycin A and erythromycin B , 1971, Experientia.

[17]  A. Myers,et al.  Synthesis of D-Desosamine and Analogs by Rapid Assembly of 3-Amino Sugars. , 2016, Angewandte Chemie.

[18]  R. Andrade.  Total Synthesis of Desmethyl Macrolide Antibiotics , 2015, Synlett.

[19]  A. Bashan,et al.  Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus , 2015, Proceedings of the National Academy of Sciences.

[20]  A. R. English,et al.  Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution , 1987, Antimicrobial Agents and Chemotherapy.

[21]  R. K. Boeckman,et al.  Studies directed toward the synthesis of naturally occurring acyltetramic acids. 2. Preparation of the macrocyclic subunit of ikarugamycin , 1986 .

[22]  E. Negishi,et al.  An Efficient and General Method for the Synthesis of α,ω‐Difunctional Reduced Polypropionates by Zr‐Catalyzed Asymmetric Carboalumination: Synthesis of the Scyphostatin Side Chain (I). , 2004 .

[23]  H. Ramu,et al.  Inducible Resistance to Macrolide Antibiotics , 2012 .

[24]  A. Mankin,et al.  Macrolide antibiotics: binding site, mechanism of action, resistance. , 2003, Current topics in medicinal chemistry.

[25]  B Wilkinson,et al.  Engineering broader specificity into an antibiotic-producing polyketide synthase. , 1998, Science.

[26]  E. Negishi,et al.  An efficient and general method for the synthesis of alpha,omega-difunctional reduced polypropionates by Zr-catalyzed asymmetric carboalumination: synthesis of the scyphostatin side chain. , 2004, Angewandte Chemie.

[27]  Fan Liu,et al.  Development of a platform for the discovery and practical synthesis of new tetracycline antibiotics. , 2016, Current opinion in chemical biology.

[28]  A. R. English,et al.  Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-AZA-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides. , 1988, The Journal of antibiotics.

[29]  E. Santaniello,et al.  An Efficient Chemoenzymatic Approach to the Enantioselective Synthesis of 2‐Methyl‐1,3‐propanediol Derivatives. , 1991 .

[30]  C. Walsh,et al.  Harnessing the biosynthetic code: combinations, permutations, and mutations. , 1998, Science.

[31]  Ronald N. Jones,et al.  CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria. , 2010, Diagnostic microbiology and infectious disease.

[32]  R. K. Boeckman,et al.  A new, highly efficient, selective methodology for formation of medium-ring and macrocyclic lactones via intramolecular ketene trapping: an application to a convergent synthesis of (−)-kromycin , 1989 .

[33]  K. Nambiar,et al.  Asymmetric total synthesis of erythromycin. 3. Total synthesis of erythromycin , 1981 .

[34]  J. W. Smith,et al.  [Ilotycin, a new antibiotic]. , 1952, Schweizerische medizinische Wochenschrift.

[35]  Y. Kawakami,et al.  Enantioselective catalysis of ketoester-ene reaction of silyl enol ether to construct quaternary carbons by chiral dicationic palladium(II) complexes. , 2007, Journal of the American Chemical Society.

[36]  Jaron A. M. Mercer,et al.  Stereocontrolled synthesis of syn-β-Hydroxy-α-amino acids by direct aldolization of pseudoephenamine glycinamide. , 2014, Angewandte Chemie.

[37]  D. Klepacki,et al.  Binding and Action of CEM-101, a New Fluoroketolide Antibiotic That Inhibits Protein Synthesis , 2010, Antimicrobial Agents and Chemotherapy.

[38]  J. Retsema,et al.  Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms , 1987, Antimicrobial Agents and Chemotherapy.

[39]  T. Steitz,et al.  Revisiting the structures of several antibiotics bound to the bacterial ribosome , 2010, Proceedings of the National Academy of Sciences.

[40]  C. Aring,et al.  A CRITICAL REVIEW , 1939, Journal of neurology and psychiatry.

[41]  A. Bryskier.  Ketolides-telithromycin, an example of a new class of antibacterial agents. , 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[42]  E. Santaniello,et al.  An efficient chemo-enzymatic approach to the enantioselective synthesis of 2-methyl-1,3-propamedical derivatives , 1990 .

[43]  C. Walsh.  Antibiotics: Actions, Origins, Resistance , 2003 .

[44]  Gregor Blaha,et al.  Structures of MLSBK Antibiotics Bound to Mutated Large Ribosomal Subunits Provide a Structural Explanation for Resistance , 2005, Cell.

[45]  C. Khosla.  Harnessing the Biosynthetic Potential of Modular Polyketide Synthases. , 1997, Chemical reviews.